Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001128732-16-000016
Filing Date
2016-04-25
Accepted
2016-04-25 07:30:03
Documents
1
Period of Report
2016-04-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3034
  Complete submission text file 0001128732-16-000016.txt   4650
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 731 PLACE DE L'EEAU VIVE LAVAL A8 H7Y 2E1
Business Address
MERZOUKI ABDERRAZZAK (Reporting) CIK: 0001636418 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52898 | Film No.: 161587887